Literature DB >> 19735458

Mutated ERBB4: a novel drug target in metastatic melanoma?

Kari Kurppa, Klaus Elenius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19735458     DOI： 10.1111/j.1755-148X.2009.00635.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  7 in total

1.  Activating ERBB4 mutations in non-small cell lung cancer.

Authors:  K J Kurppa; K Denessiouk; M S Johnson; K Elenius
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

Review 2.  The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors.

Authors:  M R Schneider; Y Yarden
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

3.  Extracting Fitness Relationships and Oncogenic Patterns among Driver Genes in Cancer.

Authors:  Xindong Zhang; Lin Gao; Songwei Jia
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

Review 4.  A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.

Authors:  Mohammed I El-Gamal; Nada H Mewafi; Nada E Abdelmotteleb; Minnatullah A Emara; Hamadeh Tarazi; Rawan M Sbenati; Moustafa M Madkour; Seyed-Omar Zaraei; Afnan I Shahin; Hanan S Anbar
Journal:  Molecules       Date:  2021-12-05       Impact factor: 4.411

Review 5.  ErbB4 in the brain: Focus on high grade glioma.

Authors:  Jamie-Lee Pitcher; Naomi Alexander; Panimaya Jeffreena Miranda; Terrance G Johns
Journal:  Front Oncol       Date:  2022-08-31       Impact factor: 5.738

6.  Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.

Authors:  T O Nielsen; S Sorensen; F Dagnæs-Hansen; J Kjems; B S Sorensen
Journal:  Br J Cancer       Date:  2013-05-21       Impact factor: 7.640

7.  miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.

Authors:  Mingxin Zhang; Qi Yang; Lingmin Zhang; Suna Zhou; Wenguang Ye; Qinglin Yao; Zongfang Li; Cheng Huang; Qinsheng Wen; Jingjie Wang
Journal:  J Exp Clin Cancer Res       Date:  2014-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.